Codexis Inc (CDXS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Codexis Inc (CDXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9868
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Codexis Inc (Codexis) is a protein engineering company, which develops proteins for a wide range of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, industrial enzymes and fine chemicals, and enzymes as biotherapeutics and for use in molecular diagnostics. The company discovers, identifies, optimizes and produces enzymes by using its technology platforms such as CodeEvolver, protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. It also offers a wide range of biocatalysis solutions ranging from screening and optimization to commercial supply of biocatalysts. The company serves specialist businesses, pharmaceutical, food manufacturing and chemical companies. Codexis is headquartered in Redwood City, California, the US.

Codexis Inc (CDXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Codexis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Codexis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Codexis Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Codexis Enters into Agreement with Nestle Health Science 10
Codexis Enters into R&D Agreement with Biopharmaceutical Company 12
Purolite Enters Into Co-Development Agreement With Codexis For Immobilized Enzymes 13
Strem Chemicals Enters Into Distribution Agreement With Codexis For Codex Screening Kits 14
Albany Molecular Research Enters Into Smartsourcing Partnership With Codexis 15
Licensing Agreements 16
Porton Pharma Enters into Licensing Agreement with Codexis 16
Merck Enters into Licensing Agreement with Codexis for CodeEvolver Platform Technology 17
Codexis Enters into Licensing Agreement with GlaxoSmithKline for CodeEvolver Protein Engineering Platform 19
Merck Extends Licensing Agreement with Codexis 21
Equity Offering 22
Codexis Prices Public Offering of Shares for USD34.6 Million 22
Codexis Raises USD25.3 Million in Public Offering of Shares 24
Asset Transactions 26
Intrexon Acquires Laboratory Operations From Codexis US$1.5 Million 26
Codexis Inc – Key Competitors 27
Codexis Inc – Key Employees 28
Codexis Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 08, 2018: Codexis reports second quarter 2018 financial results 30
May 10, 2018: Codexis Reports First Quarter 2018 Financial Results 32
Mar 08, 2018: Codexis Reports 2017 Fourth Quarter and Full Year Financial Results 34
Nov 09, 2017: Codexis Reports Financial Results for the Third Quarter of 2017 36
Aug 09, 2017: Codexis Reports Financial Results for the Second Quarter of 2017 38
May 09, 2017: Codexis Reports Financial Results for the First Quarter of 2017 40
Mar 09, 2017: Codexis Reports 2016 Fourth Quarter and Full Year Financial Results 41
Legal and Regulatory 43
Feb 06, 2018: EnzymeWorks Resumes Focus on Biocatalysis 43
Aug 08, 2017: Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks 44
Product News 45
Jan 06, 2017: Codexis to Offer High-Performance Enzymes for Diagnostics Markets 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Codexis Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Codexis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Codexis Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Codexis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Codexis Enters into Agreement with Nestle Health Science 10
Codexis Enters into R&D Agreement with Biopharmaceutical Company 12
Purolite Enters Into Co-Development Agreement With Codexis For Immobilized Enzymes 13
Strem Chemicals Enters Into Distribution Agreement With Codexis For Codex Screening Kits 14
Albany Molecular Research Enters Into Smartsourcing Partnership With Codexis 15
Porton Pharma Enters into Licensing Agreement with Codexis 16
Merck Enters into Licensing Agreement with Codexis for CodeEvolver Platform Technology 17
Codexis Enters into Licensing Agreement with GlaxoSmithKline for CodeEvolver Protein Engineering Platform 19
Merck Extends Licensing Agreement with Codexis 21
Codexis Prices Public Offering of Shares for USD34.6 Million 22
Codexis Raises USD25.3 Million in Public Offering of Shares 24
Intrexon Acquires Laboratory Operations From Codexis US$1.5 Million 26
Codexis Inc, Key Competitors 27
Codexis Inc, Key Employees 28
Codexis Inc, Subsidiaries 29

List of Figures
Codexis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Codexis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Codexis Inc (CDXS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The TJX Companies, Inc. (TJX):企業の財務・戦略的SWOT分析
    The TJX Companies, Inc. (TJX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • China Gezhouba Group Co Ltd (600068):企業の財務・戦略的SWOT分析
    China Gezhouba Group Co Ltd (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Wells Fargo Private Bank:企業の戦略・SWOT・財務分析
    Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Northbridge Financial Corporation:企業の戦略的SWOT分析
    Northbridge Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Taubman Centers Inc:企業の戦略的SWOT分析
    Taubman Centers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Avebe U.A.:企業の戦略的SWOT分析
    Avebe U.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Do & Co Poland Sp.Z.O.O:企業の戦略・SWOT・財務分析
    Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report Summary Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Northern Oil & Gas Inc (NOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Northern Oil & Gas Inc (Northern) is an oil and gas company that offers acquisition, exploration and production services. The company acquires and maintains oil and natural gas properties in Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana. It offers s …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sumitomo Realty & Development Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • OrthoAccel Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary OrthoAccel Technologies Inc (AcceleDent) is a medical device company that manufactures, develops, and markets orthodontic treatment and dental care products. The company’s products include acceledent aura is an accelerated tooth movement device designed for faster orthodontic treatment based …
  • Radboud University Nijmegen Medical Centre-製薬・医療分野:企業M&A・提携分析
    Summary Radboud University Nijmegen Medical Centre (Radboud UMC), a subsidiary of Radboud University is a university medical center that offers patient care, research, and scientific training services. The centre’s patient care services include basic care, tertiary care, top referral care, and trans …
  • TUI Group:企業の戦略・SWOT・財務情報
    TUI Group - Strategy, SWOT and Corporate Finance Report Summary TUI Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Agios Pharmaceuticals Inc (AGIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Polyplex (Thailand) Public Company Limited
    Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Expeditors International of Washington, Inc.:企業の戦略・SWOT・財務情報
    Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report Summary Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Harley-Davidson Inc (HOG):企業の財務・戦略的SWOT分析
    Harley-Davidson Inc (HOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cummins Inc.:企業の戦略・SWOT・財務分析
    Cummins Inc. - Strategy, SWOT and Corporate Finance Report Summary Cummins Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Otonomy Inc (OTIC):製薬・医療:M&Aディール及び事業提携情報
    Summary Otonomy Inc (Otonomy) develops and markets treatments for diseases and disorders of the ear. The company’s Otiprio is the US FDA approved ciprofloxacin otic suspension indicated during tympanostomy tube placement surgery in pediatric patients. Its pipeline portfolio encompasses Otividex for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆